RecruitingPhase 1NCT04473781

Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer

Prospective Study of Interstitial Brachytherapy for Unresectable/Unablatable T1b/T2a Renal Masses


Sponsor

Jonsson Comprehensive Cancer Center

Enrollment

17 participants

Start Date

Jul 16, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This phase I/II trial investigates the side effects of interstitial brachytherapy and to see how well it works in limiting the growth of large kidney cancer masses in patients with kidney cancer that have refused or are unable to undergo surgery or ablation (unresectable/unablatable). Brachytherapy, also known as internal radiation therapy, temporarily introduces a radiation source into or near the tumor to eradicate the tumor cells. Giving brachytherapy may potentially reduce the size of the kidney cancer mass that would otherwise not be amenable to surgical management and translate into lower risk of spread.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing interstitial brachytherapy — a procedure where radioactive seeds are placed directly inside a kidney tumor through the skin — as a treatment for kidney cancer in patients who cannot or will not have surgery, and whose tumors also cannot be treated by standard ablation techniques. **You may be eligible if:** - You have kidney cancer confirmed by biopsy - Your tumor is between 4 and 10 cm in size - Your tumor is mostly solid (at least 80% solid) and has been growing over at least 6 months - You are not a candidate for or are unwilling to have surgery - Your tumor cannot be reliably treated with standard ablation - You have not received prior treatment for kidney cancer - You are in good general health (ECOG less than 2) - You have adequate blood, liver, and kidney function **You may NOT be eligible if:** - Your cancer has spread to lymph nodes or distant organs - You are pregnant - You have an active autoimmune or inflammatory condition - You have a coagulation or bleeding disorder that would make the procedure unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREInterstitial Radiation Therapy

Undergo interstitial brachytherapy


Locations(1)

UCLA / Jonsson Comprehensive Cancer Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04473781


Related Trials